— Know what they know.
Not Investment Advice
Also trades as: 0LJL.L (LSE) · $vol 0M · UHID (OTC) · $vol 0M

UHS NYSE

Universal Health Services, Inc.
1W: -4.9% 1M: -10.2% 3M: -29.5% YTD: -26.1% 1Y: -16.8% 3Y: +22.3% 5Y: +4.2%
$157.80
-4.65 (-2.86%)
 
Weekly Expected Move ±6.0%
$148 $158 $169 $179 $189
NYSE · Healthcare · Medical - Care Facilities · Alpha Radar Sell · Power 36 · $9.9B mcap · 50M float · 1.66% daily turnover · Short 68% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 12.4%  ·  5Y Avg: 9.4%
Cost Advantage
51
Intangibles
39
Switching Cost
57
Network Effect
57
Scale ★
60
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. UHS shows a Weak competitive edge (51.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 12.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$190
Low
$224
Avg Target
$310
High
Based on 6 analysts since Apr 27, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 18Hold: 23Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$224.50
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-30 UBS $245 $310 +65 +84.7% $167.86
2026-04-29 Cantor Fitzgerald Initiated $194 +15.8% $167.51
2026-04-29 RBC Capital $231 $190 -41 +16.9% $162.54
2026-04-29 Guggenheim $274 $211 -63 +29.8% $162.54
2026-04-29 Robert W. Baird Michael Ha $203 $204 +1 +25.5% $162.54
2026-04-28 Barclays $262 $238 -24 +32.6% $179.51
2026-01-22 Barclays $263 $262 -1 +28.6% $203.68
2026-01-07 UBS $231 $245 +14 +14.0% $214.97
2026-01-07 Wells Fargo $249 $235 -14 +6.0% $221.74
2025-12-02 Guggenheim Jason Cassorla $253 $274 +21 +14.4% $239.43
2025-11-03 Raymond James John Ransom $219 $270 +51 +24.4% $217.01
2025-10-30 UBS $302 $231 -71 +2.5% $225.30
2025-10-30 RBC Capital Ben Hendrix $189 $231 +42 +3.3% $223.61
2025-10-29 UBS $227 $302 +75 +37.7% $219.32
2025-10-29 Guggenheim Jason Cassorla Initiated $253 +15.4% $219.32
2025-10-29 Morgan Stanley Craig Hettenbach $200 $233 +33 +6.2% $219.32
2025-10-28 Barclays $256 $263 +7 +22.9% $214.03
2025-10-28 Mizuho Securities Ann Hynes $153 $242 +89 +13.1% $214.03
2025-10-14 Goldman Sachs $135 $219 +84 +10.7% $197.76
2025-10-07 Wells Fargo $154 $249 +95 +19.1% $209.11
2025-08-14 Robert W. Baird Michael Ha $274 $203 -71 +14.1% $177.91
2025-07-30 UBS $226 $227 +1 +37.2% $165.44
2025-03-26 Morgan Stanley Initiated $200 +8.4% $184.46
2024-09-04 Robert W. Baird Michael Ha $236 $274 +38 +15.9% $236.47
2024-07-26 Raymond James Sarah James Initiated $219 +6.8% $204.99
2024-07-26 Barclays Andrew Mok $142 $256 +114 +21.5% $210.68
2024-06-26 Robert W. Baird Michael Ha Initiated $236 +25.7% $187.70
2024-06-05 HSBC Sidharth Sahoo Initiated $580 +517.0% $94.00
2024-05-19 UBS AJ Rice Initiated $226 +27.2% $177.70
2024-05-07 RBC Capital Frank Morgan $130 $189 +59 +11.7% $169.15
2024-04-12 Deutsche Bank Pito Chickering Initiated $203 +20.5% $168.40
2024-04-01 Stephens Scott Fidel $135 $185 +50 +1.4% $182.46
2023-04-24 Barclays Steven Valiquette $132 $142 +10 +0.9% $140.70
2023-01-09 Barclays Initiated $132 -13.3% $152.21
2023-01-03 Wells Fargo Stephen Baxter $118 $154 +36 +8.4% $142.03
2022-07-01 Credit Suisse $158 $141 -17 +37.9% $102.23
2022-05-03 Mizuho Securities $290 $153 -137 +22.4% $124.98
2022-04-28 Wells Fargo Initiated $118 -5.0% $124.16
2022-04-27 Stephens $142 $135 -7 +8.6% $124.31
2022-04-27 Credit Suisse $181 $158 -23 +26.1% $125.32
2022-04-27 RBC Capital Initiated $130 +3.7% $125.32
2022-04-25 Mizuho Securities Ann Hynes Initiated $290 +318.0% $69.38
2021-11-08 Goldman Sachs Jamie Perse Initiated $135 +5.4% $128.04
2021-10-26 Stephens Scott Fidel Initiated $142 +14.0% $124.54
2021-10-26 BMO Capital Matthew Borsch Initiated $145 +16.4% $124.54
2021-10-25 Bank of America Securities Kevin Fischbeck Initiated $153 +21.6% $125.79
2021-07-26 Credit Suisse A.J. Rice Initiated $181 +14.2% $158.43
2021-06-20 Wolfe Research Justin Lake Initiated $171 +13.1% $151.20

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. UHS receives an overall rating of A. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-04-30 B A
2026-04-28 A B
2026-04-27 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

64 Grade A
Profitability
45
Balance Sheet
60
Earnings Quality
80
Growth
66
Value
78
Momentum
91
Safety
80
Cash Flow
40
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. UHS scores highest in Momentum (91/100) and lowest in Cash Flow (40/100). An overall grade of A places UHS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.05
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
0.50
Possible Manipulator
Ohlson O-Score
-8.29
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 73.9/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.25x
Accruals: -2.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. UHS scores 3.05, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. UHS scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. UHS's score of 0.50 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. UHS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. UHS receives an estimated rating of A (score: 73.9/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). UHS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
6.34x
PEG
0.19x
P/S
0.56x
P/B
1.28x
P/FCF
12.35x
P/OCF
5.79x
EV/EBITDA
5.88x
EV/Revenue
0.92x
EV/EBIT
7.57x
EV/FCF
18.36x
Earnings Yield
13.77%
FCF Yield
8.09%
Shareholder Yield
8.68%
Graham Number
$255.67
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 6.3x earnings, UHS trades at a deep value multiple. An earnings yield of 13.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $255.67 per share, suggesting a potential 62% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.753
NI / EBT
×
Interest Burden
0.932
EBT / EBIT
×
EBIT Margin
0.122
EBIT / Rev
×
Asset Turnover
1.167
Rev / Assets
×
Equity Multiplier
2.182
Assets / Equity
=
ROE
21.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. UHS's ROE of 21.8% is driven by Asset Turnover (1.167), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
37.04%
Fair P/E
82.58x
Intrinsic Value
$2035.12
Price/Value
0.09x
Margin of Safety
91.21%
Premium
-91.21%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with UHS's realized 37.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $2035.12, UHS appears undervalued with a 91% margin of safety. The adjusted fair P/E of 82.6x compares to the current market P/E of 6.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$157.69
Median 1Y
$151.52
5th Pctile
$81.28
95th Pctile
$281.76
Ann. Volatility
37.7%
Analyst Target
$224.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marc D. Miller,
Chief Executive Officer and President
$1,430,769 $9,999,904 $16,148,937
Alan B. Miller,
Executive Chairman
$1,073,077 $5,062,102 $8,073,195
Steve G. Filton,
Executive Vice President and Chief Financial Officer
$853,299 $2,450,025 $5,108,695
Edward H. Sim,
Executive Vice President and President, Acute Care (6.)
$802,024 $2,290,465 $4,764,989
Matthew J. Peterson,
Executive Vice President and President, Behavioral Health
$719,971 $2,012,660 $4,176,437

CEO Pay Ratio

199:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $16,148,937
Avg Employee Cost (SGA/emp): $81,111
Employees: 101,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
101,500
+2.5% YoY
Revenue / Employee
$171,082
Rev: $17,364,829,000
Profit / Employee
$14,668
NI: $1,488,796,000
SGA / Employee
$81,111
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 18.3% 17.9% 16.0% 15.1% 12.5% 11.9% 11.2% 11.4% 11.5% 11.3% 11.9% 13.5% 15.5% 17.0% 17.8% 18.7% 19.7% 21.5% 21.4% 21.8% 21.82%
ROA 8.6% 8.4% 7.4% 7.0% 5.8% 5.6% 5.1% 5.1% 5.2% 5.1% 5.2% 5.9% 6.8% 7.5% 8.0% 8.4% 8.9% 9.7% 9.8% 10.0% 10.00%
ROIC 12.3% 12.0% 9.9% 9.4% 7.9% 7.6% 6.9% 7.2% 7.5% 7.6% 7.9% 8.7% 9.8% 10.5% 11.4% 11.7% 12.1% 13.0% 12.1% 12.4% 12.37%
ROCE 13.8% 13.4% 12.4% 11.7% 9.8% 9.4% 8.5% 8.9% 9.2% 9.3% 9.6% 10.6% 11.9% 12.9% 13.7% 14.3% 14.9% 16.1% 16.7% 17.0% 17.04%
Gross Margin 89.4% 88.3% 88.6% 88.7% 89.3% 89.0% 88.9% 89.0% 89.3% 89.4% 89.4% 89.5% 90.1% 90.2% 90.1% 90.2% 90.2% 90.8% 90.6% 14.6% 14.64%
Operating Margin 13.7% 10.0% 9.6% 7.1% 7.0% 8.3% 7.6% 8.0% 7.9% 8.0% 8.9% 10.1% 11.2% 9.7% 11.5% 11.1% 11.7% 11.6% 11.5% 11.2% 11.19%
Net Margin 10.1% 6.9% 7.3% 4.7% 4.9% 5.5% 5.1% 4.7% 4.8% 4.7% 5.8% 6.8% 7.4% 6.5% 8.1% 7.7% 8.2% 8.3% 9.9% 7.8% 7.76%
EBITDA Margin 18.2% 14.0% 14.0% 11.1% 11.4% 12.4% 12.0% 11.7% 11.7% 11.5% 12.9% 13.8% 14.8% 13.5% 15.2% 14.8% 15.4% 15.3% 17.5% 14.6% 14.64%
FCF Margin 1.4% -1.0% 0.2% 3.5% 3.5% 1.8% 2.0% 1.0% 3.7% 2.9% 3.7% 4.0% 5.5% 6.2% 7.1% 6.6% 5.5% 5.6% 4.8% 5.0% 5.03%
OCF Margin 8.4% 5.7% 7.0% 9.7% 9.5% 7.7% 7.4% 6.2% 8.5% 7.9% 8.9% 9.4% 11.3% 12.1% 13.1% 12.6% 11.5% 11.5% 10.7% 10.7% 10.73%
ROE 3Y Avg snapshot only 17.38%
ROE 5Y Avg snapshot only 15.81%
ROA 3Y Avg snapshot only 7.88%
ROIC 3Y Avg snapshot only 8.83%
ROIC Economic snapshot only 12.37%
Cash ROA snapshot only 11.94%
Cash ROIC snapshot only 15.07%
CROIC snapshot only 7.07%
NOPAT Margin snapshot only 8.81%
Pretax Margin snapshot only 11.38%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 35.16%
SBC / Revenue snapshot only 0.41%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 11.33 10.70 10.23 11.57 9.51 8.58 14.77 13.11 15.97 12.82 14.44 15.20 13.36 15.12 10.49 10.34 9.32 9.65 9.44 7.26 6.336
P/S Ratio 1.00 0.91 0.80 0.84 0.56 0.48 0.74 0.66 0.80 0.62 0.73 0.85 0.83 1.01 0.76 0.77 0.71 0.78 0.81 0.62 0.556
P/B Ratio 1.94 1.79 1.66 1.78 1.21 1.04 1.68 1.52 1.87 1.46 1.69 2.02 2.03 2.52 1.80 1.86 1.76 1.99 1.93 1.52 1.280
P/FCF 72.20 -91.07 361.00 24.04 15.94 26.28 38.06 64.73 21.71 21.07 19.75 21.01 14.98 16.22 10.67 11.71 13.03 13.98 16.92 12.35 12.354
P/OCF 11.91 16.09 11.45 8.60 5.93 6.21 10.01 10.66 9.43 7.79 8.17 9.03 7.39 8.34 5.80 6.09 6.18 6.81 7.54 5.79 5.795
EV/EBITDA 7.47 7.12 7.64 8.27 7.19 6.68 9.64 8.77 9.83 8.41 9.13 9.63 8.89 9.79 7.42 7.34 6.83 7.01 7.08 5.88 5.876
EV/Revenue 1.25 1.15 1.15 1.18 0.91 0.82 1.13 1.04 1.18 0.99 1.09 1.20 1.18 1.35 1.06 1.07 1.01 1.07 1.12 0.92 0.924
EV/EBIT 10.06 9.71 10.60 11.73 10.86 10.29 15.32 13.70 15.16 12.88 13.66 13.94 12.45 13.51 10.01 9.82 9.06 9.15 9.14 7.57 7.573
EV/FCF 89.71 -114.96 519.52 33.93 25.55 44.70 57.79 102.02 31.87 33.62 29.75 29.89 21.28 21.70 14.97 16.28 18.39 19.07 23.39 18.36 18.360
Earnings Yield 8.8% 9.3% 9.8% 8.6% 10.5% 11.6% 6.8% 7.6% 6.3% 7.8% 6.9% 6.6% 7.5% 6.6% 9.5% 9.7% 10.7% 10.4% 10.6% 13.8% 13.77%
FCF Yield 1.4% -1.1% 0.3% 4.2% 6.3% 3.8% 2.6% 1.5% 4.6% 4.7% 5.1% 4.8% 6.7% 6.2% 9.4% 8.5% 7.7% 7.2% 5.9% 8.1% 8.09%
PEG Ratio snapshot only 0.192
Price/Tangible Book snapshot only 3.441
EV/OCF snapshot only 8.612
EV/Gross Profit snapshot only 1.296
Acquirers Multiple snapshot only 8.038
Shareholder Yield snapshot only 8.68%
Graham Number snapshot only $255.67
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.32 1.32 1.14 1.14 1.14 1.14 1.33 1.33 1.33 1.33 1.40 1.40 1.40 1.40 1.27 1.27 1.27 1.27 1.05 1.05 1.052
Quick Ratio 1.25 1.25 1.04 1.04 1.04 1.04 1.21 1.21 1.21 1.21 1.29 1.29 1.29 1.29 1.17 1.17 1.17 1.17 0.98 0.98 0.980
Debt/Equity 0.66 0.66 0.75 0.75 0.75 0.75 0.89 0.89 0.89 0.89 0.87 0.87 0.87 0.87 0.74 0.74 0.74 0.74 0.76 0.76 0.757
Net Debt/Equity 0.47 0.47 0.73 0.73 0.73 0.73 0.87 0.87 0.87 0.87 0.85 0.85 0.85 0.85 0.72 0.72 0.72 0.72 0.74 0.74 0.738
Debt/Assets 0.31 0.31 0.35 0.35 0.35 0.35 0.39 0.39 0.39 0.39 0.38 0.38 0.38 0.38 0.34 0.34 0.34 0.34 0.35 0.35 0.345
Debt/EBITDA 2.06 2.09 2.39 2.47 2.78 2.82 3.36 3.27 3.20 3.20 3.14 2.93 2.69 2.53 2.19 2.11 2.04 1.92 2.01 1.97 1.971
Net Debt/EBITDA 1.46 1.48 2.33 2.41 2.71 2.75 3.29 3.21 3.13 3.14 3.07 2.86 2.63 2.47 2.13 2.06 1.99 1.87 1.96 1.92 1.922
Interest Coverage 16.68 17.15 16.71 15.88 12.66 10.36 7.79 6.61 5.96 5.45 5.52 6.05 6.80 7.64 8.96 10.02 11.43 12.89 13.63 14.21 14.215
Equity Multiplier 2.13 2.13 2.15 2.15 2.15 2.15 2.28 2.28 2.28 2.28 2.27 2.27 2.27 2.27 2.17 2.17 2.17 2.17 2.19 2.19 2.193
Cash Ratio snapshot only 0.043
Debt Service Coverage snapshot only 18.319
Cash to Debt snapshot only 0.025
FCF to Debt snapshot only 0.162
Defensive Interval snapshot only 94.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.97 0.99 0.95 0.97 0.98 1.00 1.01 1.02 1.04 1.06 1.04 1.07 1.09 1.12 1.11 1.13 1.16 1.20 1.14 1.17 1.167
Inventory Turnover 7.83 8.02 7.18 7.31 7.39 7.38 6.93 6.97 7.09 7.15 7.04 7.15 7.18 7.24 7.25 7.25 7.39 7.50 7.32 22.48 22.483
Receivables Turnover 7.42 7.57 7.27 7.44 7.51 7.61 7.12 7.21 7.33 7.45 6.71 6.89 7.06 7.25 7.17 7.28 7.45 7.70 7.27 7.43 7.431
Payables Turnover 2.70 2.76 2.32 2.36 2.39 2.39 2.28 2.29 2.33 2.35 2.45 2.49 2.50 2.52 2.55 2.55 2.60 2.64 2.40 7.37 7.370
DSO 49 48 50 49 49 48 51 51 50 49 54 53 52 50 51 50 49 47 50 49 49.1 days
DIO 47 46 51 50 49 49 53 52 51 51 52 51 51 50 50 50 49 49 50 16 16.2 days
DPO 135 132 157 155 153 153 160 159 157 155 149 147 146 145 143 143 141 138 152 50 49.5 days
Cash Conversion Cycle -40 -38 -56 -56 -55 -56 -56 -56 -55 -55 -43 -43 -43 -44 -42 -43 -42 -42 -52 16 15.8 days
Fixed Asset Turnover snapshot only 2.406
Operating Cycle snapshot only 65.4 days
Cash Velocity snapshot only 128.887
Capital Intensity snapshot only 0.898
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 8.3% 9.5% 9.4% 10.0% 6.9% 6.2% 6.0% 5.0% 5.8% 6.0% 6.6% 8.0% 8.8% 9.9% 10.8% 9.7% 9.6% 10.2% 9.7% 10.4% 10.42%
Net Income 47.2% 20.6% 5.2% -7.3% -28.4% -30.2% -31.8% -26.8% -10.6% -8.5% 6.3% 19.3% 35.0% 51.7% 59.1% 46.6% 35.0% 34.0% 30.4% 27.1% 27.06%
EPS 46.3% 22.9% 13.0% 4.6% -17.6% -20.1% -24.3% -22.1% -6.1% -4.0% 11.4% 24.5% 40.8% 55.1% 62.6% 52.0% 41.0% 40.5% 35.6% 36.0% 35.96%
FCF -89.3% -1.1% -98.3% -60.3% 1.7% 2.9% 8.3% -69.2% 10.1% 70.5% 1.0% 3.3% 63.8% 1.3% 1.1% 78.9% 8.2% -0.8% -26.1% -15.4% -15.37%
EBITDA 25.5% 11.7% 2.2% -5.0% -19.4% -19.5% -17.7% -12.7% 0.4% 1.8% 8.9% 13.8% 21.0% 28.9% 32.4% 27.8% 21.6% 21.7% 21.1% 19.2% 19.16%
Op. Income 33.2% 13.9% 0.3% -8.3% -26.9% -27.9% -26.4% -19.3% 0.1% 4.7% 17.1% 22.5% 31.5% 39.3% 43.1% 36.0% 25.7% 26.5% 18.6% 16.8% 16.83%
OCF Growth snapshot only -6.14%
Asset Growth snapshot only 10.28%
Equity Growth snapshot only 9.14%
Debt Growth snapshot only 11.14%
Shares Change snapshot only -6.55%
Dividend Growth snapshot only -4.83%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 5.0% 5.3% 5.5% 5.9% 5.7% 5.6% 5.6% 6.0% 7.0% 7.3% 7.3% 7.7% 7.1% 7.4% 7.8% 7.6% 8.1% 8.7% 9.0% 9.4% 9.37%
Revenue 5Y 5.3% 5.3% 5.3% 5.4% 5.2% 5.2% 5.2% 5.3% 5.5% 5.6% 5.8% 6.1% 6.3% 6.5% 6.8% 7.1% 7.9% 8.4% 8.5% 8.6% 8.63%
EPS 3Y 13.7% 12.0% 13.9% 12.3% 5.1% 7.2% 0.4% 4.7% 4.2% -1.9% -1.6% 0.5% 2.9% 6.0% 11.1% 13.8% 23.1% 27.9% 34.9% 37.0% 37.04%
EPS 5Y 12.2% 12.1% 11.6% 10.8% 7.1% 6.6% 3.5% 3.3% 2.6% 1.5% 4.5% 6.6% 8.9% 12.9% 12.9% 16.8% 17.6% 15.5% 16.0% 16.0% 15.97%
Net Income 3Y 10.1% 8.0% 8.3% 5.8% -1.1% 0.6% -6.0% -1.7% -2.0% -8.3% -8.6% -6.8% -4.7% -1.0% 4.9% 8.6% 17.7% 23.0% 30.2% 30.5% 30.49%
Net Income 5Y 9.1% 8.6% 7.1% 5.4% 1.5% 0.9% -2.1% -2.3% -3.1% -4.3% -1.6% 0.7% 3.1% 7.2% 7.0% 10.7% 11.4% 9.4% 9.6% 8.6% 8.58%
EBITDA 3Y 6.0% 5.2% 5.1% 3.7% -0.7% 0.4% -3.0% 0.0% 0.5% -2.9% -2.9% -1.9% -0.7% 1.9% 5.9% 8.3% 13.9% 16.9% 20.4% 20.1% 20.12%
EBITDA 5Y 3.9% 3.6% 2.6% 1.8% -0.6% -0.8% -1.8% -1.1% -0.7% -1.0% 0.8% 2.1% 3.5% 5.8% 5.7% 7.8% 8.4% 7.5% 8.0% 7.5% 7.54%
Gross Profit 3Y 4.8% 5.1% 5.3% 5.7% 5.5% 5.5% 5.6% 6.0% 7.0% 7.4% 7.5% 7.9% 7.5% 7.8% 8.3% 8.1% 8.6% 9.3% 9.6% 1.6% 1.57%
Gross Profit 5Y 5.2% 5.2% 5.1% 5.3% 5.1% 5.1% 5.1% 5.2% 5.5% 5.6% 5.8% 6.2% 6.4% 6.7% 7.1% 7.4% 8.1% 8.7% 8.9% 4.0% 3.97%
Op. Income 3Y 6.1% 5.3% 5.1% 3.2% -3.1% -2.4% -6.2% -1.9% -0.9% -4.9% -4.7% -3.2% -1.3% 1.7% 7.3% 10.4% 18.3% 22.7% 25.7% 24.8% 24.85%
Op. Income 5Y 3.1% 2.6% 1.2% 0.3% -3.0% -3.4% -4.8% -3.6% -2.7% -2.5% 0.0% 1.7% 3.7% 6.3% 6.7% 9.5% 10.0% 8.7% 8.0% 7.6% 7.58%
FCF 3Y -32.6% -62.4% -8.9% -8.4% -31.8% -30.3% -46.0% -31.5% -39.8% -31.4% -19.5% 70.0% 2.4% 32.9% 25.0% 57.9% 46.9% 86.2% 86.15%
FCF 5Y -11.2% -26.8% 28.7% -14.5% -19.4% -1.7% -3.0% -0.2% -0.2% 6.7% 4.7% 7.7% 3.7% -10.6% -12.9% -12.6% -4.6% -4.64%
OCF 3Y -7.0% -18.1% -13.0% -2.8% -2.4% -10.3% -11.5% -18.4% -19.7% -24.7% -18.7% -10.7% 18.0% 38.3% 32.7% 17.3% 15.2% 24.0% 23.2% 31.3% 31.34%
OCF 5Y -4.4% -11.9% -7.3% -0.8% 4.0% -0.9% -3.4% -4.6% -1.7% -2.8% -1.1% 0.1% 4.8% 5.6% 7.5% 5.6% -3.5% -5.7% -4.6% -0.2% -0.25%
Assets 3Y 7.8% 7.8% 5.1% 5.1% 5.1% 5.1% 5.0% 5.0% 5.0% 5.0% 1.2% 1.2% 1.2% 1.2% 3.4% 3.4% 3.4% 3.4% 5.7% 5.7% 5.75%
Assets 5Y 7.0% 7.0% 4.9% 4.9% 4.9% 4.9% 4.6% 4.6% 4.6% 4.6% 4.4% 4.4% 4.4% 4.4% 4.4% 4.4% 4.4% 4.4% 3.4% 3.4% 3.44%
Equity 3Y 8.2% 8.2% 4.2% 4.2% 4.2% 4.2% 2.5% 2.5% 2.5% 2.5% -0.9% -0.9% -0.9% -0.9% 3.1% 3.1% 3.1% 3.1% 7.1% 7.1% 7.11%
Book Value 3Y 11.7% 12.2% 9.6% 10.6% 10.6% 11.0% 9.5% 9.2% 8.9% 9.6% 6.7% 6.8% 7.1% 6.1% 9.1% 8.0% 7.8% 7.2% 11.0% 12.5% 12.49%
Dividend 3Y -10.7% 17.3% 64.1% 64.9% 29.8% 12.9% 2.7% 3.1% 3.6% 4.8% 5.8% 6.0% 6.2% 5.6% 4.5% 3.8% 3.7% 2.8% 2.3% 3.3% 3.30%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.98 0.96 0.97 0.96 0.95 0.94 0.95 0.95 0.97 0.96 0.97 0.97 0.98 0.97 0.96 0.97 0.98 0.98 0.98 0.98 0.980
Earnings Stability 0.54 0.71 0.94 0.59 0.17 0.15 0.03 0.02 0.02 0.05 0.08 0.00 0.01 0.04 0.04 0.19 0.25 0.24 0.33 0.39 0.391
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.91 0.906
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.81 0.92 0.98 0.97 0.89 0.88 0.87 0.89 0.96 0.97 0.97 0.92 0.86 0.50 0.50 0.81 0.86 0.86 0.88 0.89 0.892
Earnings Smoothness 0.62 0.81 0.95 0.92 0.67 0.64 0.62 0.69 0.89 0.91 0.94 0.82 0.70 0.59 0.54 0.62 0.70 0.71 0.74 0.76 0.762
ROE Trend 0.03 0.02 0.01 0.01 -0.03 -0.04 -0.04 -0.04 -0.03 -0.03 -0.02 -0.00 0.03 0.05 0.06 0.06 0.05 0.07 0.06 0.05 0.053
Gross Margin Trend -0.00 -0.00 -0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 -0.18 -0.184
FCF Margin Trend -0.08 -0.13 -0.10 -0.05 -0.04 -0.06 -0.05 -0.06 0.01 0.03 0.03 0.02 0.02 0.04 0.04 0.04 0.01 0.01 -0.01 -0.00 -0.003
Sustainable Growth Rate 17.7% 17.1% 14.9% 14.0% 11.5% 10.9% 10.3% 10.4% 10.6% 10.3% 11.0% 12.6% 14.6% 16.1% 17.0% 17.8% 18.9% 20.7% 20.6% 21.1% 21.09%
Internal Growth Rate 9.1% 8.7% 7.5% 7.0% 5.7% 5.4% 4.9% 4.9% 5.0% 4.9% 5.1% 5.9% 6.8% 7.6% 8.3% 8.7% 9.3% 10.3% 10.4% 10.7% 10.70%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.95 0.66 0.89 1.35 1.60 1.38 1.48 1.23 1.69 1.65 1.77 1.68 1.81 1.81 1.81 1.70 1.51 1.42 1.25 1.25 1.253
FCF/OCF 0.16 -0.18 0.03 0.36 0.37 0.24 0.26 0.16 0.43 0.37 0.41 0.43 0.49 0.51 0.54 0.52 0.47 0.49 0.45 0.47 0.469
FCF/Net Income snapshot only 0.588
OCF/EBITDA snapshot only 0.682
CapEx/Revenue 7.0% 6.6% 6.8% 6.2% 6.0% 5.9% 5.5% 5.2% 4.8% 5.0% 5.2% 5.3% 5.7% 5.9% 6.0% 6.1% 6.1% 5.9% 6.0% 5.7% 5.70%
CapEx/Depreciation snapshot only 1.617
Accruals Ratio 0.00 0.03 0.01 -0.02 -0.04 -0.02 -0.02 -0.01 -0.04 -0.03 -0.04 -0.04 -0.06 -0.06 -0.07 -0.06 -0.04 -0.04 -0.02 -0.03 -0.025
Sloan Accruals snapshot only -0.070
Cash Flow Adequacy snapshot only 1.794
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.3% 0.4% 0.7% 0.6% 0.8% 0.9% 0.6% 0.6% 0.5% 0.6% 0.5% 0.4% 0.4% 0.3% 0.4% 0.4% 0.4% 0.4% 0.4% 0.5% 0.51%
Dividend/Share $0.40 $0.60 $0.83 $0.84 $0.83 $0.82 $0.81 $0.81 $0.81 $0.81 $0.81 $0.80 $0.80 $0.79 $0.80 $0.81 $0.81 $0.80 $0.80 $0.82 $0.80
Payout Ratio 3.1% 4.8% 6.7% 6.8% 8.0% 8.1% 8.7% 8.4% 8.2% 8.3% 7.7% 6.7% 5.8% 5.2% 4.7% 4.5% 4.2% 3.8% 3.4% 3.3% 3.33%
FCF Payout Ratio 20.0% 2.4% 14.2% 13.3% 24.8% 22.3% 41.7% 11.2% 13.7% 10.6% 9.3% 6.5% 5.6% 4.7% 5.0% 5.9% 5.5% 6.2% 5.7% 5.67%
Total Payout Ratio 37.8% 78.2% 1.3% 1.8% 1.9% 1.7% 1.3% 89.2% 77.3% 81.5% 84.0% 80.7% 67.4% 62.0% 63.4% 67.3% 68.5% 66.8% 68.5% 63.1% 63.07%
Div. Increase Streak 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number -0.35 0.45 2.81 2.75 0.83 0.20 -0.11 -0.09 -0.07 -0.05 -0.05 -0.05 -0.05 -0.04 -0.03 -0.02 -0.02 -0.03 -0.04 -0.04 -0.044
Buyback Yield 3.1% 6.9% 12.1% 14.6% 19.3% 18.5% 8.4% 6.2% 4.3% 5.7% 5.3% 4.9% 4.6% 3.8% 5.6% 6.1% 6.9% 6.5% 6.9% 8.2% 8.22%
Net Buyback Yield 3.0% 6.7% 11.9% 14.5% 19.1% 18.3% 8.2% 6.0% 4.2% 5.6% 5.1% 4.8% 4.5% 3.7% 5.5% 6.0% 6.8% 6.4% 6.8% 8.1% 8.07%
Total Shareholder Return 3.2% 7.2% 12.6% 15.1% 19.9% 19.2% 8.8% 6.7% 4.7% 6.2% 5.7% 5.2% 4.9% 4.0% 5.9% 6.4% 7.2% 6.8% 7.1% 8.5% 8.53%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.76 0.76 0.77 0.77 0.77 0.78 0.78 0.78 0.77 0.77 0.76 0.77 0.77 0.77 0.76 0.76 0.75 0.75 0.75 0.75 0.753
Interest Burden (EBT/EBIT) 0.94 0.94 0.94 0.94 0.92 0.91 0.88 0.85 0.84 0.82 0.82 0.84 0.86 0.87 0.89 0.90 0.91 0.92 0.93 0.93 0.932
EBIT Margin 0.12 0.12 0.11 0.10 0.08 0.08 0.07 0.08 0.08 0.08 0.08 0.09 0.09 0.10 0.11 0.11 0.11 0.12 0.12 0.12 0.122
Asset Turnover 0.97 0.99 0.95 0.97 0.98 1.00 1.01 1.02 1.04 1.06 1.04 1.07 1.09 1.12 1.11 1.13 1.16 1.20 1.14 1.17 1.167
Equity Multiplier 2.13 2.13 2.14 2.14 2.14 2.14 2.21 2.21 2.21 2.21 2.28 2.28 2.28 2.28 2.22 2.22 2.22 2.22 2.18 2.18 2.182
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $12.63 $12.65 $12.42 $12.29 $10.40 $10.11 $9.40 $9.57 $9.77 $9.71 $10.47 $11.92 $13.76 $15.07 $17.03 $18.13 $19.40 $21.16 $23.10 $24.64 $24.64
Book Value/Share $73.78 $75.50 $76.43 $80.08 $81.81 $83.35 $82.47 $82.82 $83.58 $85.04 $89.70 $89.79 $90.53 $90.28 $99.39 $100.95 $102.57 $102.57 $112.87 $117.90 $123.98
Tangible Book/Share $28.43 $29.09 $26.70 $27.97 $28.58 $29.11 $28.01 $28.13 $28.39 $28.89 $32.34 $32.37 $32.64 $32.55 $39.61 $40.24 $40.88 $40.88 $49.79 $52.01 $52.01
Revenue/Share $142.60 $148.84 $158.67 $169.94 $175.29 $181.05 $186.64 $189.88 $194.79 $201.45 $208.34 $214.04 $221.11 $226.37 $235.98 $243.56 $253.27 $261.46 $269.38 $287.79 $290.84
FCF/Share $1.98 $-1.49 $0.35 $5.91 $6.21 $3.30 $3.65 $1.94 $7.18 $5.91 $7.65 $8.62 $12.27 $14.05 $16.75 $16.00 $13.87 $14.61 $12.88 $14.49 $14.64
OCF/Share $12.01 $8.41 $11.09 $16.53 $16.69 $13.97 $13.87 $11.77 $16.54 $15.98 $18.49 $20.06 $24.88 $27.33 $30.82 $30.75 $29.24 $29.98 $28.92 $30.88 $31.21
Cash/Share $14.30 $14.63 $1.45 $1.52 $1.55 $1.58 $1.43 $1.44 $1.45 $1.48 $1.74 $1.74 $1.76 $1.75 $1.88 $1.91 $1.94 $1.94 $2.14 $2.23 $1.95
EBITDA/Share $23.80 $23.98 $23.94 $24.27 $22.07 $22.11 $21.88 $22.54 $23.29 $23.63 $24.96 $26.78 $29.38 $31.13 $33.77 $35.50 $37.34 $39.71 $42.55 $45.26 $45.26
Debt/Share $48.99 $50.13 $57.22 $59.96 $61.25 $62.41 $73.42 $73.74 $74.41 $75.71 $78.29 $78.37 $79.01 $78.80 $73.88 $75.04 $76.25 $76.25 $85.43 $89.24 $89.24
Net Debt/Share $34.68 $35.49 $55.78 $58.44 $59.70 $60.83 $71.99 $72.30 $72.96 $74.23 $76.55 $76.62 $77.26 $77.04 $72.00 $73.13 $74.31 $74.31 $83.30 $87.01 $87.01
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.050
Altman Z-Prime snapshot only 3.972
Piotroski F-Score 6 7 5 6 5 6 8 8 7 8 9 9 9 9 8 8 8 8 8 7 7
Beneish M-Score -2.36 -2.27 -2.43 -2.58 -2.64 -2.57 -2.46 -2.40 -2.51 -2.50 -2.57 -2.56 -2.63 -2.66 -2.79 -2.77 -2.70 -2.67 -2.39 0.50 0.503
Ohlson O-Score snapshot only -8.291
ROIC (Greenblatt) snapshot only 28.71%
Net-Net WC snapshot only $-83.28
EVA snapshot only $299968895.68
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A
Credit Score 72.25 67.17 66.19 67.87 68.63 61.76 63.49 61.31 61.78 61.76 61.61 69.84 69.32 72.27 73.54 76.31 75.69 78.19 73.82 73.93 73.933
Credit Grade snapshot only 6
Credit Trend snapshot only -2.377
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 70
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms